FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...

Format Comparison for Needle-Free GLP-1 Options, Administration Preferences, and Telehealth Access PathwaysHOUSTON, TX, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational ...

This review highlights relevant physicochemical drug properties and formulation design considerations critical to quality and performance of the sublingual tablets. The oral mucosal lining offers a ...

NEW YORK, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Not Medical Advice: Read Before Proceeding This article is a market analysis for informational purposes only and does not constitute medical advice. "Best" ...

Lannett announced that the Food and Drug Administration (FDA) has approved Buprenorphine and Naloxone Sublingual Tablets, the generic version of Reckitt Benckiser's Suboxone Sublingual Tablets.

Aspire does not expect to conduct additional studies beyond its currently planned multicenter crossover clinical trial. ・The ...

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study Patients receiving stable opioid therapy ...

First sublingual tablet for grass allergies approved The FDA has cleared the once-daily tablet Oralair to treat grass-pollen induced allergic rhinitis with or without conjunctivitis. HealthDay News — ...

Allergens modified by carbamylation so that they can be absorbed by the oral mucosa and given as sublingual immunotherapy have once again been found to be effective in patients with ...

Needle-Free Growth Hormone Support via Telehealth - Platform Analysis Compares Compounded Prescription Tablets vs. Injectable Format as Consumer Search Volume for "Sermorelin Alternative" Climbs 340% ...